Viewing Study NCT05622058


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-02 @ 9:44 AM
Study NCT ID: NCT05622058
Status: TERMINATED
Last Update Posted: 2023-02-27
First Post: 2022-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Sponsor: Aileron Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module